Pharmaceutical Technology's In the Lab eNewsletter, May 2022

May 04, 2022

The “cloud lab” is a virtual laboratory setting that can enable scientists to more quickly advance research.

May 04, 2022

It is vital to consider optimal cleaning and disinfection practices when operating a cleanroom.

May 04, 2022

Standard BioTools’ new Hyperion+ Imaging System can process more samples and has lower limits of detection than their current product.

May 04, 2022

FDA granted Quanterix’s neurofilament light chain plasma test a breakthrough device designation as a prognostic aid for relapsing-remitting multiple sclerosis.

May 04, 2022

Accelerate Diagnostics’ new blood culture kit demonstrated 94% or greater accuracy on positive blood cultures relative to matrix-assisted laser desorption/ionization (MALDI).

April 29, 2022

Bio-Rad Laboratories introduces three new fluorescent dyes under the StarBright product range to support multicolor flow cytometry panels.

April 29, 2022

A new range of five instruments for ultra-low-volume liquid dispensing for microarray and microfluidics applications, Mercury, has been introduced by Arrayjet.

April 29, 2022

CN Bio’s PhysioMimix “in-a-box” reagent kit is designed to harness liver-on-a-chip technology to improve accuracy and efficiency in drug discovery.

April 18, 2022

AmoyDX has entered a Master Collaboration Agreement with AstraZeneca for multiple companion diagnostics programs in China, EU, and Japan.

April 13, 2022

VectorBuilder will expand with the construction of new $500 million Gene Delivery Research and Manufacturing Campus in Guangzhou, China.

April 12, 2022

Biomarker-guided trial led by University Hospital Hamburg-Eppendorf (UKE) opens new avenues for personalized medicine for treatment of COVID-19.

April 11, 2022

Ymmunobio AG has signed a patent purchase agreement with LeukoCom GmbH to expand its development of cancer therapies.